eCite Digital Repository
Clopidogrel prescribing and concordance with the Pharmaceutical Benefits Scheme in hospital patients
Citation
Luinstra, M and Naunton, M and Peterson, GM and Bereznicki, LRE, Clopidogrel prescribing and concordance with the Pharmaceutical Benefits Scheme in hospital patients, Journal of Pharmacy Practice and Research , 39, (4) pp. 265-268. ISSN 1445-937X (2009) [Refereed Article]
 | PDF Restricted - Request a copy 762Kb |
Copyright Statement
Copyrights 2009 The Society of Hospital Pharmacists of Australia
DOI: doi:10.1002/j.2055-2335.2009.tb00471.x
Abstract
Background: Clopidogrel is used for the secondary prevention
of cerebrovascular and cardiovascular events. Clopidogrel has
a similar safety profile to low-dose aspirin but is considerably
more expensive. Clopidogrel is subsidised for restricted
indications via the Pharmaceutical Benefits Scheme (PBS).
Aim: To examine c1opidogrel prescribing in hospital; and to
identify patients discharged on clopidogrel according to PBS
criteria.
Method: Cross-sectional evaluation of patients started on
clopidogrel (July 2006 to June 2007) at the Royal Darwin and
Royal Hobart Hospitals.Clopidogrel prescribing was examined
and the indication for discharge on c1opidogrel was documented.
The primary outcome was concordance between clopidogrel
use and PBS criteria.
Results: Data were collected for 385 patients. 54% of patients
from the Royal Darwin Hospital and 39% of patients from the
Royal Hobart Hospital discharged on c1opidogrel met PBS
criteria.The main reason for noncompliance with the PBS was
absenceof a history of cardiovascularor cerebrovascularevents
while on low-dose aspirin and an absence of contraindications
to aspirin at the time of c1opidogrel prescribing.
Conclusion: Although c1opidogrel prescribing at the hospitals
was often not in accordance with PBS criteria, in most cases
prescribing was based on the available evidence.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | clopidogrel, prevention, cardiovascular, data, research, hospital patients, Pharmaceutical Benefits Scheme |
| Research Division: | Medical and Health Sciences |
| Research Group: | Pharmacology and Pharmaceutical Sciences |
| Research Field: | Clinical Pharmacology and Therapeutics |
| Objective Division: | Health |
| Objective Group: | Clinical Health (Organs, Diseases and Abnormal Conditions) |
| Objective Field: | Cardiovascular System and Diseases |
| UTAS Author: | Luinstra, M (Ms Marianne Luinstra) |
| UTAS Author: | Peterson, GM (Professor Gregory Peterson) |
| UTAS Author: | Bereznicki, LRE (Professor Luke Bereznicki) |
| ID Code: | 60281 |
| Year Published: | 2009 |
| Deposited By: | Pharmacy |
| Deposited On: | 2010-01-28 |
| Last Modified: | 2010-06-16 |
| Downloads: | 1 View Download Statistics |
Repository Staff Only: item control page